Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S. U. Berlangieri is active.

Publication


Featured researches published by S. U. Berlangieri.


Molecular Imaging and Biology | 2008

Role of Low-dose, Noncontrast Computed Tomography from Integrated Positron Emission Tomography/Computed Tomography in Evaluating Incidental 2-Deoxy-2-[F-18]fluoro-d-glucose-avid Colon Lesions

Sze Ting Lee; T. Tan; Aurora Poon; H. B. Toh; S. Gill; S. U. Berlangieri; E. Kraft; Amanda J. Byrne; Kunthi Pathmaraj; G. J. O’Keefe; Niall C. Tebbutt; Andrew M. Scott

PurposeTo assess the contribution of concurrent low-dose, noncontrast CT in the assessment of the malignant potential of incidental focal 2-deoxy-2-[F-18]fluoro-d-glucose (FDG)-avid colonic lesions on positron emission tomography/computed tomography (PET/CT).ProceduresRoutine FDG-PET/CT scans were reviewed for identification of focal FDG-avid colon lesions, and the CT component was independently reviewed for an anatomical lesion and malignant potential based on CT criteria. Clinical, endoscopic, and histopathology follow-up was obtained.ResultsA total of 85/2,916 (3%) oncology FDG-PET/CT scans had incidental focal colon lesions. Clinical and/or endoscopic follow-up was available in 83/85 (98%) patients. Focal, corresponding CT lesions were found in 44/83 (53%) patients, but features of malignancy were not assessable. Of the 44 patients with a final diagnosis, 32/44 (73%) were FDG-PET/CT true positives; 5/44 (11%) were false positives; and 7/44 (16%) had inconclusive FDG-PET/CT findings.ConclusionsConcurrent low-dose, noncontrast CT improves localization, but does not provide independent information on the malignant potential of incidental focal colonic activity on FDG-PET/CT.


Internal Medicine Journal | 2007

Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.

Sze-Ting Lee; S. U. Berlangieri; Aurora Poon; Paul Mitchell; K. Pathmaraj; K. Tabone; A. J. Byrne; G. J. O’Keefe; S. R. Knight; Clarke Cp; Andrew M. Scott

Background: Accurate staging of lung cancer is essential in determining the most appropriate management plan, as detection of occult metastasis can significantly alter management.


Clinical Nuclear Medicine | 1999

F-18 fluorodeoxyglucose PET and Ga-67 citrate scintigraphy in a case of AIDS lymphoma and pericarditis

Pointon O; Andrew M. Scott; S. U. Berlangieri; McKay Wj; Goldstein D

A 32-year-old patient with AIDS was examined by Ga-67 citrate and F-18 FDG PET to stage biopsy-proved gastric non-Hodgkins lymphoma. The Ga-67 scan showed increased uptake in the stomach, lungs, and pericardium. The PET study was consistent with lymphomatous involvement in the stomach and lung apices, but no abnormality was evident in the pericardium. The pericardium was not examined by biopsy given the absence of significant symptoms and no large pericardial effusion. The disparity between the Ga-67 and the FDG findings in this region suggested an inflammatory process rather than lymphomatous involvement and highlights the multiple diseases encountered in patients with AIDS.


Journal of Nuclear Medicine Technology | 2005

Radiation Dose to PET Technologists and Strategies to Lower Occupational Exposure

Fiona O. Roberts; Dishan H. Gunawardana; Kunthi Pathmaraj; Anthony Wallace; Paul L. U; Tian Mi; S. U. Berlangieri; Graeme O’Keefe; Christopher C. Rowe; Andrew M. Scott


Molecular Imaging and Biology | 2009

Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma

Sze Ting Lee; M. Ghanem; Rebecca A. Herbertson; S. U. Berlangieri; Amanda J. Byrne; K. Tabone; Paul Mitchell; Simon R. Knight; M. Feigen; Andrew M. Scott


Australasian Physical & Engineering Sciences in Medicine | 1999

Positron emission tomography: radioisotope and radiopharmaceutical production.

Henri Tochon-Danguy; John Sachinidis; Gary F. Egan; Chan Jg; S. U. Berlangieri; McKay Wj; Andrew M. Scott


The Medical Journal of Australia | 1998

Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer.

Thomas Dm; Paul Mitchell; S. U. Berlangieri; Henri Tochon-Danguy; Simon R. Knight; Clarke Cp; Andrew M. Scott


Annals Academy of Medicine Singapore | 2013

Periarticular FDG Uptake on PET/CT in malignant melanoma-metastatic or misleading?

Gerald Jit Shen Tan; Sze-Ting Lee; S. U. Berlangieri; Andrew M. Scott


Molecular Imaging and Biology | 2009

Prognostic Value of 18 F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma

Sze Ting Lee; M. Ghanem; Rebecca A. Herbertson; S. U. Berlangieri; Amanda J. Byrne; K. Tabone; Paul Mitchell; Simon R. Knight; M. Feigen; Andrew M. Scott


Molecular Imaging and Biology | 2009

Prognostic Value of 18

Sze-Ting Lee; M. Ghanem; Rebecca A. Herbertson; S. U. Berlangieri; Amanda J. Byrne; K. Tabone; Paul Mitchell; Simon R. Knight; M. Feigen; Andrew M. Scott

Collaboration


Dive into the S. U. Berlangieri's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Aurora Poon

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Simon R. Knight

Royal College of Surgeons of England

View shared research outputs
Top Co-Authors

Avatar

K. Tabone

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Sze-Ting Lee

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rebecca A. Herbertson

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Sze Ting Lee

Ludwig Institute for Cancer Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge